- Home
- RLAY vs QD Comparison
RLAY vs QD Comparison
Compare RLAY & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- QD
- Stock Information
- Founded
- RLAY 2015
- QD 2014
- Country
- RLAY United States
- QD China
- Employees
- RLAY N/A
- QD N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- QD Finance: Consumer Services
- Sector
- RLAY Health Care
- QD Finance
- Exchange
- RLAY Nasdaq
- QD Nasdaq
- Market Cap
- RLAY 610.3M
- QD 538.3M
- IPO Year
- RLAY 2020
- QD 2017
- Fundamental
- Price
- RLAY $3.54
- QD $4.68
- Analyst Decision
- RLAY Strong Buy
- QD
- Analyst Count
- RLAY 12
- QD 0
- Target Price
- RLAY $18.45
- QD N/A
- AVG Volume (30 Days)
- RLAY 2.8M
- QD 595.6K
- Earning Date
- RLAY 08-07-2025
- QD 08-13-2025
- Dividend Yield
- RLAY N/A
- QD N/A
- EPS Growth
- RLAY N/A
- QD N/A
- EPS
- RLAY N/A
- QD 0.42
- Revenue
- RLAY $8,355,000.00
- QD $19,058,373.00
- Revenue This Year
- RLAY $17.59
- QD N/A
- Revenue Next Year
- RLAY N/A
- QD N/A
- P/E Ratio
- RLAY N/A
- QD $11.06
- Revenue Growth
- RLAY N/A
- QD N/A
- 52 Week Low
- RLAY $1.78
- QD $1.69
- 52 Week High
- RLAY $10.72
- QD $4.73
- Technical
- Relative Strength Index (RSI)
- RLAY 52.25
- QD 72.96
- Support Level
- RLAY $3.31
- QD $4.06
- Resistance Level
- RLAY $3.61
- QD $4.54
- Average True Range (ATR)
- RLAY 0.21
- QD 0.27
- MACD
- RLAY -0.02
- QD 0.05
- Stochastic Oscillator
- RLAY 68.67
- QD 96.39
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.